Premium
Human platelet antigens frequencies in Maori and Polynesian populations
Author(s) -
Edinur H. A.,
Dunn P. P. J.,
Lea R. A.,
Chambers G. K.
Publication year - 2013
Publication title -
transfusion medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.471
H-Index - 59
eISSN - 1365-3148
pISSN - 0958-7578
DOI - 10.1111/tme.12061
Subject(s) - genotyping , biology , allele , population , haplotype , genetics , ancestry informative marker , human leukocyte antigen , allele frequency , genotype , evolutionary biology , immunology , antigen , medicine , gene , environmental health
SUMMARY Background Allele frequencies of human platelet antigens ( HPA ) reflect population history and possibility of platelet‐specific alloimmunization. Here, we report on screening of variants at HPA loci for Polynesian and Maori subjects. Objectives Our aims are to evaluate new HPA genotyping methods, compile and analyse new HPA datasets for these subjects, use HPA data for tracing ancestry, migration patterns, genetic admixture and its potential influence on health. Materials and Methods A total of 75 Maori and 25 Polynesian DNA samples were genotyped using commercial BAGene HPA‐TYPE DNA‐SSP kits, BLOODchip hybridization SNP assays and DNA sequence based typing. Results Genotyping was successful and cross validation of PCR‐SSP and BLOODchip gave 100% agreement. Among the HPA loci tested, only six are dimorphic ( HPA ‐1 to ‐3, ‐5, ‐6 and ‐15) and all others are monomorphic. The Polynesians and Maori have the ‘a’ allele form as the most common for all loci except HPA ‐15. Conclusions The newly observed HPA data as well as principal coordinate analysis clearly indicate genetic contributions from both, Asia and Australasia in Maori and Polynesian populations together with recent admixture with Europeans. In addition, different prevalences of HPA alleles among Polynesian, Maori and European populations contribute towards different risk profiles for platelet‐specific alloimmunization. This is the first report for these populations and our findings are of direct practical relevance for blood transfusion centres, the management of pregnancies, assessment of neonatal alloimmune thrombocytopenia and management of multi‐transfused patients.